FDA
Lykos Wraps Up Turbulent Week with 75% Staff Cuts Following FDA Rejection and Publication Retractions
2024-08-16
SoniVie Reports Major Advancements in Renal Denervation Program for Hypertension: REDUCED-1 Results, First-In-Human Data, FDA’s Crucial IDE Approval of Global THRIVE study
2024-07-24
FDA Greenlights Eli Lilly’s Groundbreaking Alzheimer’s Drug Kisunla for Early Symptomatic Treatment
2024-07-04
Tanvex BioPharma Secures Asia’s First FDA Approval for Filgrastim Biosimilar, Seizing a $403 Million Market
2024-07-03
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Wegovy Expands Its Reach: First Weight-Loss Medication Approved to Reduce Cardiovascular Risk
2024-03-11
FDA Boxed Warning for CAR-T therapy, Affecting Bristol-Myers Squibb, Novartis, Janssen, Gilead Sciences
2024-01-24